JPMorgan Chase & Co’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,500
| Closed | -$12.2K | – | 6488 |
|
|
2024
Q1 | $12.2K | Hold |
11,500
| – | – | ﹤0.01% | 5317 |
|
|
2023
Q4 | $15.5K | Buy |
+11,500
| New | +$15.5K | ﹤0.01% | 5298 |
|
|
2022
Q1 | – | Sell |
-36,235
| Closed | -$50K | – | 5873 |
|
|
2021
Q4 | $50K | Sell |
36,235
-111,238
| -75% | -$153K | ﹤0.01% | 5072 |
|
|
2021
Q3 | $900K | Sell |
147,473
-3,200
| -2% | -$19.5K | ﹤0.01% | 3675 |
|
|
2021
Q2 | $919K | Buy |
150,673
+94,390
| +168% | +$576K | ﹤0.01% | 3698 |
|
|
2021
Q1 | $214K | Buy |
+56,283
| New | +$214K | ﹤0.01% | 4426 |
|
|
2020
Q4 | – | Sell |
-16,483
| Closed | -$101K | – | 5032 |
|
|
2020
Q3 | $101K | Buy |
16,483
+11,200
| +212% | +$68.6K | ﹤0.01% | 4043 |
|
|
2020
Q2 | $10K | Buy |
+5,283
| New | +$10K | ﹤0.01% | 4499 |
|